Literature DB >> 11115401

Cytosolic phospholipase A2-alpha associates with plasma membrane, endoplasmic reticulum and nuclear membrane in glomerular epithelial cells.

J Liu1, T Takano, J Papillon, A Khadir, A V Cybulsky.   

Abstract

Eicosanoids mediate complement-dependent glomerular epithelial injury in experimental membranous nephropathy. The release of arachidonic acid from phospholipids by cytosolic phospholipase A(2) (cPLA(2)) is the rate-limiting step in eicosanoid synthesis. The present study examines the association of cPLA(2) with membranes of organelles. Glomerular epithelial cells were disrupted by homogenization in Ca(2+)-free buffer; organelles were separated by gradient centrifugation. The distribution of cPLA(2) and organelles was analysed by immunoblotting with antibodies against cPLA(2) and organelle markers, or by enzyme assay. In cells incubated with or without the Ca(2+) ionophore ionomycin plus PMA, cPLA(2) co-localized with plasma membrane, endoplasmic reticulum and nuclei, but not with mitochondria or Golgi. A greater amount of cPLA(2) was associated with membranes in stimulated cells, but membrane-associated cPLA(2) was readily detectable under resting conditions. The pattern of association of cPLA(2) with membrane in cells treated with antibody and complement was similar to that in cells stimulated with ionomycin plus PMA; however, complement did not enhance the membrane association of cPLA(2) protein. To determine the functional role of membrane association of cPLA(2), phospholipids were labelled with [(3)H]arachidonic acid. Cells were then incubated with or without antibody and complement and were fractionated. Complement induced a loss of radioactivity from the plasma membrane, endoplasmic reticulum and nuclei, but not from the mitochondrial fraction. Thus the release of arachidonic acid by cPLA(2) is due to the hydrolysis of phospholipids at multiple subcellular membrane sites, including the endoplasmic reticulum, plasma membrane and nucleus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11115401      PMCID: PMC1221545     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Signal transduction. The calcium entry pas de deux.

Authors:  M J Berridge; P Lipp; M D Bootman
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

2.  "Cytosolic" phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation.

Authors:  M R Sierra-Honigmann; J R Bradley; J S Pober
Journal:  Lab Invest       Date:  1996-03       Impact factor: 5.662

3.  A role for thromboxane in complement-mediated glomerular injury.

Authors:  A V Cybulsky; W Lieberthal; R J Quigg; H G Rennke; D J Salant
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

4.  Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells.

Authors:  A V Cybulsky; T Takano; J Papillon; A J McTavish
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  A Ca(2+)-independent activation of a type IV cytosolic phospholipase A(2) underlies the receptor stimulation of arachidonic acid-dependent noncapacitative calcium entry.

Authors:  J L Osterhout; T J Shuttleworth
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

6.  Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells : role of cyclooxygenase-1 and -2.

Authors:  T Takano; A V Cybulsky
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

7.  Complement-induced phospholipase A2 activation in experimental membranous nephropathy.

Authors:  A V Cybulsky; T Takano; J Papillon; A J McTavish
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

8.  Enhanced glomerular prostaglandin formation in experimental membranous nephropathy.

Authors:  R A Stahl; S Adler; P J Baker; Y P Chen; P M Pritzl; W G Couser
Journal:  Kidney Int       Date:  1987-05       Impact factor: 10.612

9.  Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy.

Authors:  A V Cybulsky; H G Rennke; I D Feintzeig; D J Salant
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Indomethacin reduces proteinuria in passive Heymann nephritis in rats.

Authors:  C Zoja; A Benigni; P Verroust; P Ronco; T Bertani; G Remuzzi
Journal:  Kidney Int       Date:  1987-06       Impact factor: 10.612

View more
  6 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Arachidonic acid pools of rat kidney cell nuclei.

Authors:  Sabina M Maté; Juan P Layerenza; Ana Ves-Losada
Journal:  Mol Cell Biochem       Date:  2010-09-14       Impact factor: 3.396

3.  Complement-mediated activation of calcium-independent phospholipase A2γ: role of protein kinases and phosphorylation.

Authors:  Hanan Elimam; Joan Papillon; Tomoko Takano; Andrey V Cybulsky
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

4.  Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains.

Authors:  Sarah Vascellari; Sebastiano Banni; Claudia Vacca; Vito Vetrugno; Franco Cardone; Michele A Di Bari; Paolo La Colla; Alessandra Pani
Journal:  Lipids Health Dis       Date:  2011-08-04       Impact factor: 3.876

5.  Activation of cytosolic phospholipase A2 in dorsal root ganglion neurons by Ca2+/calmodulin-dependent protein kinase II after peripheral nerve injury.

Authors:  Shigeo Hasegawa; Yuta Kohro; Makoto Tsuda; Kazuhide Inoue
Journal:  Mol Pain       Date:  2009-05-02       Impact factor: 3.395

6.  Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.

Authors:  Clive Bate; Mourad Tayebi; Alun Williams
Journal:  BMC Biol       Date:  2008-02-12       Impact factor: 7.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.